Please ensure Javascript is enabled for purposes of website accessibility

Is a Short-Squeeze Driving Fulgent Genetics Higher?

By Danny Vena, Jason Hall, and Brian Withers - Feb 16, 2021 at 10:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The genetic testing services specialist has been on a tear.

Fulgent Genetics (FLGT -1.51%) soared in 2020, with its stock gaining more than 300%. Investors hoping for a pullback in 2021 have been disappointed, as the stock has gained a jaw-dropping 200% so far this year. This has investors wondering whether there's a short squeeze at work, or if it's something else driving the stock's stratospheric growth.

On this clip from Motley Fool Live, recorded on Jan 29, "The Wrap" host Jason Hall and Fool.com contributors Danny Vena and Brian Withers dig a little deeper into what's happening.

Brian Withers: The most voted up question is the Fulgent.

Jason Hall: Fulgent Genetics.

Brian Withers: Fulgent and I'm assuming we're talking about Fulgent Genetics.

Jason Hall: Yeah, yeah.

Brian Withers: We talked a little bit yesterday about trying to figure out whether a company was under a short squeeze. You can go to Yahoo! Finance, put in a ticker, click "Statistics", and I'm looking at short percent of float its 29%, which is actually pretty high.

Jason Hall: That's really high, yeah.

Brian Withers: The average volume over the last three months is 1.19 million and the average volume over the last ten days is 1.9 million. The volume's not up, so it's potentially some short-selling or short-squeeze happening, but it doesn't look like it's a wild run on the stock by any means.

Jason Hall: Yeah, I will say this though. This is just relatively recent recommendation in December and I think in November and a couple of different Foolish services. Since it's just a smaller company, I mean, the market has gotten a little bit bigger but still relatively smaller. Getting a recommendation for some of the Foolish services might have some role in having pushed it up.

Brian Withers: Yeah, it's only a $1.7 billion company. It's really still, yes, very small and 1.9 million shares traded on any given day is not significant.

Jason Hall: No, it's like 1% of GameStop. Which would you rather own in 10 years? A mall retailer that sells video game consoles and used video games or a company that's really good in genetics?

Brian Withers: There you go.

Jason Hall: [laughs] I'll take the biotech, that's me.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Fulgent Genetics, Inc. Stock Quote
Fulgent Genetics, Inc.
FLGT
$53.63 (-1.51%) $0.82

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.